Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately to Severely Active Crohns Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677514
What this trial is testing

A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Jiangsu Carephar Pharmaceutical Co., Ltd. 156
Large-scale testing (Phase 3)Looking for participantsNCT06332534
What this trial is testing

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 110
Large-scale testing (Phase 3)Study completedNCT02499783
What this trial is testing

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 205
Not applicableNo Longer AvailableNCT03362736
What this trial is testing

An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT02877134
What this trial is testing

Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 388
Large-scale testing (Phase 3)Study completedNCT01369342
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

Who this might be right for
Crohn's DiseaseInflammatory Bowel DiseaseIBD+1 more
Janssen Research & Development, LLC 640
Testing effectiveness (Phase 2)Study completedNCT02378688
What this trial is testing

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Tanabe Pharma Corporation 78
Large-scale testing (Phase 3)Study completedNCT03464136
What this trial is testing

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

Who this might be right for
Crohn Disease
Janssen Scientific Affairs, LLC 386
Post-approval studies (Phase 4)Looking for participantsNCT05928039
What this trial is testing

PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease

Who this might be right for
Crohn Disease
University of Calgary 297
Testing effectiveness (Phase 2)Active Not RecruitingNCT05242471
What this trial is testing

Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 703
Large-scale testing (Phase 3)Looking for participantsNCT05923073
What this trial is testing

Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 120
Large-scale testing (Phase 3)Study completedNCT03104413
What this trial is testing

Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

Who this might be right for
Crohn's Disease
AbbVie 618
Large-scale testing (Phase 3)Study completedNCT03440385
What this trial is testing

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Celgene 606
Testing effectiveness (Phase 2)Ended earlyNCT04102111
What this trial is testing

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 48
Large-scale testing (Phase 3)Ended earlyNCT03464097
What this trial is testing

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Celgene 550
Large-scale testing (Phase 3)Study completedNCT02065570
What this trial is testing

Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 514
Testing effectiveness (Phase 2)Ended earlyNCT00562887
What this trial is testing

Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Abbott 246
Testing effectiveness (Phase 2)Study completedNCT01203631
What this trial is testing

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
InflammationCrohn's Disease
Janssen Research & Development, LLC 78
Post-approval studies (Phase 4)Study completedNCT05029921
What this trial is testing

Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 182
Post-approval studies (Phase 4)WithdrawnNCT02760615
What this trial is testing

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda
Next Page